Stocks/NUVL

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

NUVL

↓ PDF (Pro)
Nuvalent Inc. Class A Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$100.69
-1.89%today
MKT CAP
$8.2B
-4.2% · 1Y
Earnings History
-21.0%
-28.9%
-10.0%
-7.7%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$100.69
Low
$116.00
Analyst Mean
$142.32
High
$165.00
18 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-41.2%
Debt / Equity-
Free Cash Flow$-188,927,744
Insider Ownership2.8%
Institutional Ownership114.3%
Short % of Float9.78%
Days to Cover7.7d
1 Week-1.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
PORTER JAMES RICHARDChief Executive OfficerSale30,000$98.54$3.05M2026-05-04
PORTER JAMES RICHARDChief Executive OfficerConversion30,000$18.93$0.57M2026-05-04
BALCOM ALEXANDRAChief Financial OfficerSale11,430$98.42$1.13M2026-05-01
BALCOM ALEXANDRAChief Financial OfficerConversion11,430$1.08$0.04M2026-05-01
MILLER DEBORAH ANNOfficerSale5,500$99.13$0.55M2026-04-30
Top Holders
HolderType% HeldValueΔ SharesAs of
Deerfield Management Company, L.Pinstitution23.48%$1.82B-4.13%2025-12-31
FMR, LLCinstitution14.78%$1.14B+8.39%2025-12-31
Paradigm Biocapital Advisors LPinstitution7.17%$0.55B+0.00%2025-12-31
Vanguard Group Incinstitution7.14%$0.55B+13.88%2025-12-31
Blackrock Inc.institution6.54%$0.51B+17.61%2025-12-31
Wellington Management Group, LLPinstitution3.35%$0.26B+7.00%2025-12-31
JPMORGAN CHASE & COinstitution3.00%$0.23B-34.13%2025-12-31
Price (T.Rowe) Associates Incinstitution2.92%$0.23B+18.59%2025-12-31
RA Capital Management, L.P.institution2.56%$0.20B+50.83%2025-12-31
State Street Corporationinstitution2.54%$0.20B+18.41%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.35%$0.18B+17.37%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fundfund1.66%$0.13B+10.43%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund1.65%$0.13B-0.18%2026-03-31
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fundfund1.65%$0.13B-17.28%2026-03-31
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fundfund1.44%$0.11B-2.05%2026-01-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund1.21%$0.09B+15.15%2026-03-31
Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd.fund1.15%$0.09B+3604.17%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fundfund1.07%$0.08B+11.27%2025-12-31
Fidelity Select Portfolios-Select Health Care Portfoliofund0.99%$0.08B-4.21%2026-03-31
JPMorgan Trust II-JPMorgan Mid Cap Growth Fundfund0.83%$0.06B-4.64%2025-12-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PCVX
Vaxcyte Inc. Common Stock
$8.2B5------0.00%
KRYS
Krystal Biotech Inc. Common Stock
$8.4B3138.127.9----0.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
IBRX
ImmunityBio Inc. Common Stock
$8.7B5------0.00%
PRAX
Praxis Precision Medicines Inc. Common Stock
$9.3B5------0.00%
CYTK
Cytokinetics Incorporated Common Stock
$9.3B-------0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for NUVL.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.